We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

GSM \u00b7 Local hormones

Low-dose vaginal estrogen: safety and use

Local vaginal estrogen \u2014 cream, tablet, ring \u2014 treats genitourinary syndrome with minimal systemic absorption. It's safe for most women, including many breast cancer survivors after individualized discussion.

Key points

  • Cream 2–3x/week
  • Tablet 2x/week
  • Ring every 3 months
  • Vaginal DHEA (prasterone) as alternative

Frequently asked questions

Is vaginal estrogen safe long-term?

Yes — decades of use with no systemic risk signal.

Do I need progesterone with it?

Generally no — endometrial exposure is negligible.

Can breast cancer survivors use it?

Often yes, after discussion with oncology.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.

Ask Dot